UNIGE document Scientific Article
previous document  unige:114050  next document
add to browser collection
Title

Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease

Authors
Agosta, Federica
Festari, Cristina
Orini, Stefania
Gandolfo, Federica
Arbizu, Javier
Bouwman, Femke
show hidden authors show all authors [1 - 13]
Published in European Journal of Nuclear Medicine and Molecular Imaging. 2018, vol. 45, no. 9, p. 1546-1556
Abstract To evaluate the incremental value of FDG-PET over clinical tests in: (i) diagnosis of amyotrophic lateral sclerosis (ALS); (ii) picking early signs of neurodegeneration in patients with a genetic risk of Huntington's disease (HD); and detecting metabolic changes related to cognitive impairment in (iii) ALS and (iv) HD patients.
Keywords Amyotrophic Lateral Sclerosis/diagnostic imagingBrainFluorodeoxyglucose F18HumansHuntington Disease/diagnostic imagingPositron-Emission TomographyRadiopharmaceuticals
Identifiers
PMID: 29717332
Full text
Article (Published version) (2.3 MB) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Troubles de mémoire et maladie d'Alzeimer (935)
Citation
(ISO format)
AGOSTA, Federica et al. Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease. In: European Journal of Nuclear Medicine and Molecular Imaging, 2018, vol. 45, n° 9, p. 1546-1556. https://archive-ouverte.unige.ch/unige:114050

61 hits

0 download

Update

Deposited on : 2019-02-08

Export document
Format :
Citation style :